News
For years UnitedHealth Group (NYSE: UNH) has normally been a reliable dividend stock. But an abysmal start to 2025 has wiped ...
5h
Benzinga on MSNUnitedHealth CEO Faces Key Test Amid Probes, Margin CollapseUnitedHealth Group CEO Stephen Hemsley faces intense investor scrutiny Tuesday as the company reports second-quarter earnings ...
The conglomerate was viewed as one of the most successful companies in America, but patients are enraged and investors have ...
UnitedHealth's newly returned CEO, Stephen Hemsley, will likely face investor scrutiny over the largest U.S. health insurance ...
Bretton Fund reviews Q2 setbacks led by UnitedHealth’s plunge, offset by gains from Microsoft and AmEx. See how fundamentals ...
UnitedHealth faces regulatory scrutiny, fraud allegations, and leadership turmoil. Click here to learn why UNH stock is a ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results